CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...
Genetic testing is transforming depression treatment by tailoring antidepressants to your DNA for better results and fewer ...
Researchers at Duke University and North Carolina State University have discovered a handful of new CRISPR-Cas systems that ...
CB-010 ANTLER 2L LBCL and CB-011 CaMMouflage r/r MM Phase 1 clinical data expected in H1 2025 ---- Advancing four clinical programs for ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Every year, we hold a STAT Madness tournament to find the best ...
This writer digs into the CRISPR gene-editing space, asking whether one particular penny stock is worth taking a punt on in his ISA. The post Could buying this gene-editing penny stock at $1 make me ...
Patients with pancreatic cancer who participate in clinical research have better outcomes. PanCAN strongly recommends clinical trials at diagnosis and during every treatment decision. Clinical trials ...
After years of research into xenotransplantation, the field is at a turning point—yet risks and ethical issues remain ...
Purdue University researchers have received $124,984 from the Trask Innovation Fund to develop Purdue-owned intellectual ...
the research team sees potential for the CRISPR diagnostic platform to detect other respiratory infections. “This tool is an ...
Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP) - a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results